Structure, function, and regulation of tartrate-resistant acid phosphatase

Bone

Volumn 27, Issue 5, 2000, Pages 575-584

  Oddie, G W ^a   Schenk, G ^a   Angel, N Z ^a   Walsh, N ^a   Guddat, L W ^a   De Jersey, J ^a   Cassady, A I ^a   Hamilton, S E ^a   Hume, D A ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; TARTARIC ACID;

ENZYME MECHANISM; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; OSTEOCLAST; OSTEOLYSIS; PROTEIN EXPRESSION; REVIEW;

ACID PHOSPHATASE; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; ISOENZYMES; SUBSTRATE SPECIFICITY;

EID: 0033759918     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(00)00368-9     Document Type: Review

References (123)

1. Transcriptional regulation of the tartrate-resistant acid phosphatase gene (TRAP) gene by iron
2. Purification and characterization of human tartrate-resistant acid phosphatase
3. Purification and characterization of purple acid phosphatase from developing rat bone
4. The tartrate-resistant purple acid phosphatase of bone osteoclasts - A protein phosphatase with multivalent substrate specificity and regulation
5. Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover
6. Mechanism of the reaction of different phosphates with the iron(II)iron(III) form of purple acid phosphatase from porcine uteri (uteroferrin)
7. Osteopontin mRNA expression during bone resorption: An in situ hybridization study of induced ectopic bone in the rat
8. Uteroferrin contains complex and high mannose-type oligosaccharides when synthesized n vitro
9. Irreversible inactivation of purple acid phosphatase by hydrogen peroxide and ascorbate
10. Enzymatically active zinc, copper and mercury derivatives of the one-iron form of pig allantoic fluid acid phosphatase
11. A putative role for c-Fos in the pathophysiology of Paget's disease
12. Transcriptional regulation of the tartrate resistant acid phosphatase (TRAP) gene by iron
13. Osteopontin-hydroxyapatite interactions in vitro - Inhibition of hydroxyapatite formation and growth in a gelatin-gel
14. Targeting simian virus 40 T antigen to the osteoclast in transgenic mice causes osteoclast tumors and transformation and apoptosis of osteoclasts
15. Tartrate-resistant acid phosphatase forms complexes with α2-macroglobulin in serum
16. Dephosphorylation of the mannose-6-phosphate recognition marker is localized in later compartments of the endocytic route. Identification of purple acid phosphatase (uteroferrin) as the candidate phosphatase
17. Iron transfer between the purple phosphatase uteroferrin and transferrin and its possible role in iron metabolism of the fetal pig
18. Iron-containing acid phosphatases: Comparison of the enzymes from beef spleen and pig allantoic fluid
19. Isolation and characterization of the genes encoding mouse and human type-5 acid phosphatase
20. Generation and characterization of monoclonal antibodies to human type-5 tartrate-resistant acid phosphatase: Development of a specific immunoassay of the isoenzyme in serum
21. Purification and properties of a progesterone induced basic glycoprotein from the uterine fluid of pigs
22. Interaction of porcine uterine fluid purple acid phosphatase with vanadate and vanadyl cation
23. Osteoclastic superoxide production and bone resorption: Stimulation and inhibition by modulators of NADPH oxidase
24. Kinetics and optical spectroscopic studies on the purple acid phosphatase from beef spleen
25. A type 5 acid phosphatase gene from Aribodopsis thaliana is induced by phosphate starvation and by some other types of phosphate mobilising/oxidative stress conditions
26. Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces - An in vitro and ex vivo study of remodeling bone
27. Antibodies to porcine uteroferrin used in measurement of human tartrate-resistant acid phosphatase
28. Tartrate-resistant acid phosphatase of human lung
29. Comparative studies of rat recombinant purple acid phosphatase and bone tartrate-resistant acid phosphatase
30. Cloning, sequence and development expression of a type 5 tartrate-resistant, acid phosphatase of rat bone
31. Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase
32. Bone resorbing fluid from osteoblasts is acidic - An in vitro micropuncture study
33. Alendronate mechanism of action: Geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro
34. Tartrate-resistant acid phosphatase: Gene structure and function
35. The human tartrate-resistant acid phosphatase (TRAP): Involvement of the hemin responsive elements (HRE) in transcriptional regulation
36. RGD-directed attachment of isolated rat osteoclasts to osteopontin, bone sialoprotein, and fibronectin
37. The further purification and properties of a phosphatase from spleen able to hydrolyse completely the phosphorus of α-casein
38. Assignment of the mouse tartrate-resistant acid phosphatase gene (Acp5) to chromosome 9
39. Crystal structure of mammalian purple acid phosphatase
40. The role of reactive oxygen intermediates in osteoclastic bone resorption
41. Tartrate-resistant acid phosphatase from human bone: Purification and development of an immunoassay
42. Tartrate-resistant acid phosphatase 5b: A novel serum marker of bone resorption
43. Characterization of serum tartrate-resistant acid phosphatase and development of a direct two-site immunoassay
44. Studies on the protein tyrosine phosphatase activity of tartrate-resistant acid phosphatase
45. Two-site immunoassays for osteoclastic tartrate-resistant acid phosphatase based on characterization of six monoclonal antibodies
46. Intracellular fragmentation degradation products by reactive oxygen products generated by tartrate-resistant acid phosphatase in osteoclasts during bone resorption
47. Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase
48. Response of biochemical markers of bone turnover to hormone replacement therapy: Impact of biological variability
49. Purification and characterization of a purple acid phosphatase from rat spleen
50. Osteoclastic tartrate-resistant acid phosphatase (Acp 5): Its localization to dendritic cells and diverse murine tissues
51. Purple acid phosphatase of the human macrophage and osteoclast. Characterization, molecular properties, and crystallization of the recombinant di-iron-oxo protein secreted by baculovirus-infected insect cells
52. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis
53. Purification and characterization of a tartrate-resistant acid phosphatase from human osteoclastoma
54. Immortalization of osteoclast precursors by targeting Bcl-XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice
55. Modulation of crystal formation by bone phosphoproteins: Structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation
56. Visualization of acidic compartments in cultured osteoclasts by use of an acidotrophic amine as a marker for low pH
57. Species specificity of monoclonal antibodies to human tartrate-resistant acid phosphatase
58. Heterogeneity among cells that express osteoclast-associated genes in developing bone
59. Tartrate-resistant bone acid phosphatase: Large-scale production and purification of the recombinant enzyme, characterization, and crystallization
60. Calcitonin inhibits osteopontin mRNA expression in isolated rabbit osteoclasts
61. Iron-containing acid phosphatases: Interaction of phosphate with the enzyme from pig allantoic fluid
62. Iron-containing acid phosphatases: Characterization of the metal-ion binding site of the enzyme from pig allantoic fluid
63. The type 5 acid phosphatase from spleen of humans with hairy cell leukemia
64. Molecular cloning of the type 5, iron-containing, tartrate-resistant acid phosphatase from human placenta
65. Oxygen derived free radicals in osteoclasts: The specificity and location of the nitroblue tetrazolium reaction
66. Mechanism of Fe(III)-Zn(II) purple acid phosphatase based on crystal structures
67. Structural relationship between the mammalian Fe(III)-Fe(II) and the Fe(III)-Zn(II) plant purple acid phosphatases
68. Comparison of the tartrate-resistant acid phosphatase in Gaucher's disease and leukemic reticuloendotheliosis
69. Biochemical properties of tartrate-resistant acid phosphatase in serum of adults and children
70. Confirmation of the assignment of the human tartrate-resistant acid phosphatase gene (ACP5) to chromosome 19
71. Purification and characterization of a secreted purple phosphatase from soybean suspension culture
72. Characterization of mouse cathepsin K gene, the gene promoter, and the gene expression
73. Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification
74. Uteroferrin and intracellular tartrate-resistant acid phosphatases are the products of the same gene
75. Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases
76. Type 5 acid phosphatase. Sequence, expression and chromosomal localization of a differentiation-associated protein of the human macrophage
77. The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts
78. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras
79. The role of IL-6 type cytokines and their receptors in bone
80. Recombinant human and mouse purple acid phosphatases: Expression and characterization
81. Probing the role of the trivalent metal in phosphate ester hydrolysis: Preparation and characterization of purple acid phosphatases containing Al(III)Zn(II) and In(III)Zn(II) active sites, including the first example of an active aluminum enzyme
82. Evidence for nonbridged coordination of p-nitrophenyl phosphate to the dinuclear Fe(III)-M(II) center in bovine spleen purple acid phosphatase during enzymatic turnover
83. Expression of osteopontin mRNA by osteoclasts and osteoblasts in modeling adult human bone
84. Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption
85. The glycosylphosphatidylinositol-anchored phosphatase from Spirodela oligorrhiza is a purple acid phosphatase
86. Continuous and discontinuous assays for phosphotyrosyl protein phosphatase activity using phosphotyrosyl peptide substrates
87. Chondroclasts and osteoclasts in bones of young rats: Comparison of ultrastructural and functional features
88. Immuno- and enzyme-histochemical detection of phosphoprotein phosphatase in rat epidermis
89. Purification and properties of the native form of the purple acid phosphatase from bovine spleen
90. Opposing actions of c-ets/PU.1 and c-myb protooncogene products in regulating the macrophage-specific promoters of the human and mouse colony-stimulating factor-1 receptor (c-fms) genes
91. Analysis of DNA binding proteins associated with hemin-induced transcriptional inhibition. The hemin response element binding protein is heterogeneous complex that includes the Ku protein
92. Characterization of the mouse tartrate-resistant acid phosphatase (TRAP) gene promoter
93. The mouse tartrate-resistant acid phosphatase gene (TRAP) contains two active promoters and is regulated by iron
94. Characterization of the 5'-flanking region of the human tartrate-resistant acid phosphatase (TRAP) gene
95. Cloning and characterization of the 5'-flanking region of the mouse tartrate-resistant acid phosphatase gene
96. Characterization and sequencing of a respiratory burst-inhibiting acid phosphatase from Francisella tularensis
97. Nitroblue tetrazolium reduction and bone resorption by osteoclasts in vitro inhibited by a manganese-based superoxide dismutase mimic
98. Possible function of carbohydrate on glycoproteins secreted by the pig uterus during pregnancy
99. A tartrate-resistant acid phosphatase from Gaucher spleen
100. Comparison of the expression and function of the transcription factor PU.1 (Spi-1 proto-oncogene) between murine macrophages and B lymphocytes
101. Interaction between PU.1 and another Ets family transcription factor promotes macrophage-specific basal transcription initiation
102. Mice deficient in lysosomal acid phosphatase develop lysosomal storage in the kidney and central nervous system
103. Confocal laser scanning microscopic study [corrected] or tartrate-resistant acid phosphatase-positive cells in the dental follicle during early morphogenesis of mouse embryonic molar teeth
104. Microphthalmia-associated transcription factor interacts with PU.1 and c-fos: Determination of their subcellular localization
105. Identification of mammalian-like purple acid phosphatases in a wide range of plants
106. Occurrence of enzymes of free radicals metabolism suggests the possible cytotoxic capacity of the transitional epithelium of the human ureter
107. Histochemical investigations on the localizations of the purple acid phosphatase in the bovine spleen
108. Bisphosphonates
109. Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant mice
110. 1-Naphthylmethylphosphonic acid derivatives as osteoclastic acid phosphatase inhibitors
111. Hydroxyl radical formation and iron-binding proteins. Stimulation by the purple acid phosphatases
112. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts
113. Osteoclast radical interactions: NADPH causes pulsatile release of NO and stimulates superoxide production
114. NADPH-oxidase expression and in situ production of superoxide by osteoclasts actively resorbing bone
115. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences
116. Crystal structure of a purple acid phosphatase containing a dinuclear Fe(III)-Zn(II) active site
117. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1
118. Murine osteoclasts and spleen cell polykaryons are distinguished by mRNA phenotyping
119. Crystal structure of a mammalian purple acid phosphatase
120. X-ray absorption spectroscopic studies of the FeZn derivative of uteroferrin
121. Age-resolving osteopetrosis: A rat model implicating microphthalmia and the related transcription factor TFE3
122. Studies on the catalytic mechanism of pig purple acid phosphatase
123. Inhibition of osteoclastic acid phosphatase abolishes bone resorption